[Breast cancer in men histopathology and biomarkers]. / Brystkreft hos menn histopatologi og biomarkører.
Tidsskr Nor Laegeforen
; 144(5)2024 04 23.
Article
en Nor
| MEDLINE
| ID: mdl-38651722
ABSTRACT
Background:
Breast cancer in men accounts for around 1 % of all cases of the disease. The study aimed to identify histopathological parameters and selected biomarkers in men with breast cancer. Material andmethod:
Retrospective study of archival material from 53 men diagnosed with breast cancer at the department of pathology, Haukeland University Hospital, in the period 1996-2020. The prevalence of the oestrogen receptor (ER), progesterone receptor (PGR) and Human Epidermal Growth Factor (HER2) biomarkers was examined.Results:
Median age at time of diagnosis was 72 years. Median tumour diameter was 24 mm. Forty-nine tumours were classified histologically as invasive carcinoma of no special type (NST), 29 tumours were histologic grade 2 and 18 were grade 3. Fifty-two tumours were ER positive, 39 were PGR positive and four were HER2 positive. Twenty-five patients had lymph node metastases.Interpretation:
Our findings indicate that men with breast cancer are diagnosed at an older age than women, and that men have a more advanced stage than women at the time of diagnosis. The histopathology and expression of biomarkers of breast cancer differ between men and women.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Receptores de Progesterona
/
Receptores de Estrógenos
/
Biomarcadores de Tumor
/
Receptor ErbB-2
/
Neoplasias de la Mama Masculina
Límite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
Nor
Revista:
Tidsskr Nor Laegeforen
Año:
2024
Tipo del documento:
Article